Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mavuto Mukaka

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
NPJ Vaccines|July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adultsBorimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Human Vaccines & Immunotherapeutics|July 16, 2019
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteersLorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, et al.
Open Forum Infectious Diseases|January 16, 2026
<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest ThailandCindy S Chu, Khin Maung Lwin, Kathy Burgoine, et al.
Nature Medicine|April 21, 2026
A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trialSalum Mshamu, Mavuto Mukaka, Casiana Sanga, et al.
BMC Medicine|October 19, 2023
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placeboMarie A Onyamboko, Peter Olupot-Olupot, Winifred Were, et al.
BMJ Open|July 21, 2021
Economic and social impacts of COVID-19 and public health measures: results from an anonymous online survey in Thailand, Malaysia, the UK, Italy and SloveniaAnne Osterrieder, Giulia Cuman, Wirichada Pan-Ngum, et al.
The Lancet. Infectious Diseases|September 29, 2022
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trialRupam Tripura, Lorenz von Seidlein, Siv Sovannaroth, et al.
Nature Communications|July 18, 2025
Characterisation of between-cluster heterogeneity in malaria cluster randomised trials to inform future sample size calculationsJoseph Biggs, Joseph D Challenger, Dominic Dee, et al.
BMC Infectious Diseases|May 9, 2025
Operational evaluation of the deployment of Malaria/CRP Duo and Dengue Duo rapid diagnostic tests for the management of febrile illness by village malaria workers in rural CambodiaMarc T Visser, Dysoley Lek, Bipin Adhikari, et al.
Diagnostics (Basel, Switzerland)|January 11, 2025
The Accuracy of the Passive Leg Raising Test Using the Perfusion Index to Identify Preload Responsiveness-A Single Center Study in a Resource-Limited SettingMarialessia Casazzo, Luigi Pisani, Rabiul Alam Md Erfan Uddin, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
NPJ Vaccines|July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adultsBorimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Human Vaccines & Immunotherapeutics|July 16, 2019
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteersLorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, et al.
Open Forum Infectious Diseases|January 16, 2026
<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest ThailandCindy S Chu, Khin Maung Lwin, Kathy Burgoine, et al.
Nature Medicine|April 21, 2026
A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trialSalum Mshamu, Mavuto Mukaka, Casiana Sanga, et al.
BMC Medicine|October 19, 2023
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placeboMarie A Onyamboko, Peter Olupot-Olupot, Winifred Were, et al.
BMJ Open|July 21, 2021
Economic and social impacts of COVID-19 and public health measures: results from an anonymous online survey in Thailand, Malaysia, the UK, Italy and SloveniaAnne Osterrieder, Giulia Cuman, Wirichada Pan-Ngum, et al.
The Lancet. Infectious Diseases|September 29, 2022
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trialRupam Tripura, Lorenz von Seidlein, Siv Sovannaroth, et al.
Nature Communications|July 18, 2025
Characterisation of between-cluster heterogeneity in malaria cluster randomised trials to inform future sample size calculationsJoseph Biggs, Joseph D Challenger, Dominic Dee, et al.
BMC Infectious Diseases|May 9, 2025
Operational evaluation of the deployment of Malaria/CRP Duo and Dengue Duo rapid diagnostic tests for the management of febrile illness by village malaria workers in rural CambodiaMarc T Visser, Dysoley Lek, Bipin Adhikari, et al.
Diagnostics (Basel, Switzerland)|January 11, 2025
The Accuracy of the Passive Leg Raising Test Using the Perfusion Index to Identify Preload Responsiveness-A Single Center Study in a Resource-Limited SettingMarialessia Casazzo, Luigi Pisani, Rabiul Alam Md Erfan Uddin, et al.
Pageof 15